glp 1 disorders The rapid rise of GLP-1 receptor agonists presents a complex dilemma for clinicians managing patients with eating disorders. While these medications show potential in reducing binge eating behaviors by targeting brain reward Can one drug do it
Description
In addition, diabetes is a known risk factor for inadequate bowel prep ( Eur J Gastroenterol Hepatol 2018;30[8]:819-826), and previous research found a link between inadequate prep in diabetic patients and GLP-1 use but not in nondiabetic patients using GLP-1s ( Front Pharmacol 2023;14:1176206
& Dong, Y
Gradual Weight Loss and Muscle Maintenance For those using GLP-1 drugs primarily for weight loss, microdosing might offer a more gradual weight loss experience, which some individuals believe helps preserve muscle mass
Clinical trials show weight losses of ~6%16%
They are herbal supplement patches that borrowed a prescription drug category name for marketing purposes
